Losartan Potassium Tablet, Film Coated
Product Images NDC 65862-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 65862-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losartan Fig1

Losartan Fig1
This is a partial result of a study that compared the adjusted risk reduction between Atenolol and Losartan Potassium. The text provides a graph that displays the risk reduction percentage over the span of 66 Study Months. Not enough context has been given to determine the purpose or nature of the study.*
FDA Label Image

Losartan Fig2

FDA Label Image

Figure 3 (Losartan Fig3)

Figure 3 (Losartan Fig3)
The text cannot be evaluated due to its mixed-up content. Therefore, it is not-available.*
FDA Label Image

Figure-4 (Losartan Fig4)

Figure-4 (Losartan Fig4)
This is a tabular data. It shows the results of a clinical trial study comparing Losttan Potassium against Placebo for a certain event in patients. The table indicates that out of the total patients, 60% of those who received Losttan Potassium had the event while 40% of those who received Placebo had the same event. Additionally, the risk reduction was calculated to be 16.1%, and the P-value was found to be 0.022. The text also mentions Losttan Potassium and Placebo as the two groups compared in the study.*
FDA Label Image

Losartan Fig5

Losartan Fig5
This is a medication label for Losartan Potassium tablets manufactured by Aurbindo Pharma USA. Each film-coated tablet contains an unspecified quantity of the active ingredient. The recommended adult dosage instructions are not available in the given text. The drug is to be stored at a room temperature between 20° to 25°C in a light-protected container. The label suggests that the medication is a prescription drug and was manufactured in India. There is an overprinting zone and coding area on the label.*
FDA Label Image

Losartan Fig6

Losartan Fig6
Losartan Potassium is a medication sold in the form of tablets USP and is only available by prescription. This particular package contains 30 tablets, each with 50mg of Losartan Potassium. The recommended storage temperature range is between 20-25 degrees Celsius (68°-77°F). This medication is manufactured by Aurobindo Pharma and has been quality-controlled in a USP controlled room. Additional information, including the purpose of the medication, dosage, and precautions, is not available due to the limited text provided.*
FDA Label Image

Losartan Fig7

Losartan Fig7
This is a description of a medication called "Losartan Potassium". The tablets are distributed by a company named "Aurtinga Phara USA" and the dosage is 100mg. There are 30 tablets in a pack with a code printed on the box. The purpose of the medication is not available.*
FDA Label Image

Chemical Structure (Losartan Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.